SCHEMBL6045121

SCHEMBL6045121

CCC(O)c1ccc2cc(N(C)C)ccc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 1/20 0.47
LMNA P02545 1/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2D6 P10635 2/20 0.41
MEN1 O00255 1/20 0.41
TSHR P16473 1/20 0.41
KMT2A Q03164 1/20 0.41
HIF1A Q16665 1/20 0.41
TERT O14746 1/20 0.40
APP P05067 1/20 0.40
GAA P10253 2/20 0.40
SLC6A2 P23975 4/20 0.38
SLC6A4 P31645 4/20 0.38
SLC6A3 Q01959 4/20 0.38
UGT2B7 P16662 1/20 0.38
RAD52 P43351 1/20 0.38
KCNH2 Q12809 1/20 0.38
PSMB5 P28074 1/20 0.37
MAPT P10636 1/20 0.37
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14515206 0.86 AOC3 (0.47) AOC3CYP1A2CYP2D6MEN1TSHR
SCHEMBL6933240 0.85 LMNA (0.54) AOC3LMNACYP1A2CYP2D6MEN1
SCHEMBL6055232 0.81 LMNA (0.56) LMNAMEN1TSHRKMT2AGAA
SCHEMBL3218170 0.80 UGT2B7 (0.60) AOC3CYP1A2CYP2D6MEN1TSHR
SCHEMBL6044687 0.80 AOC3 (0.42) AOC3CYP1A2CYP2D6MEN1TSHR
SCHEMBL6055256 0.79 LMNA (0.53) AOC3LMNACYP2D6TSHRHIF1A
SCHEMBL10120474 0.78 UGT2B7 (0.62) AOC3LMNACYP1A2CYP2D6MEN1
SCHEMBL483715 0.78 UGT2B7 (0.62) AOC3LMNACYP1A2CYP2D6MEN1
SCHEMBL15701594 0.76 TERT (0.47) AOC3LMNATSHRTERTAPP
SCHEMBL13849487 0.75 LMNA (0.44) AOC3LMNACYP1A2CYP2D6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060142311-A1 Prodan-containing nucleotide and use thereof KYOTO UNIVERSITY 2006-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060142311-A1 Prodan-containing nucleotide and use thereof PNP, NUDT1, NT5C2 AOC3 1234/4885LMNA 152/4885CYP1A2 1929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.